Loading…
Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.
Political giving
$0
Political receipts
$0
Lobbying income
$35,391,500
Lobbying expense
—
Federal awards
—
Relationships
204
| $360,000 |
| — |
| lobbied by | Novartis | $315,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America | $300,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America | $300,000 | Apr 14, 2026 – Jul 15, 2026 |
| lobbied by | Inc. Amgen | $285,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America | $270,000 | — |
| lobbied by | Seqirus | $270,000 | — |
| lobbied by | Alvogen | $270,000 | — |
| lobbied by | Fresenius Medical Care North America | $270,000 | — |
| lobbied by | Inc. Amgen | $270,000 | — |
| lobbied by | Pharmaceutical Research And Manufacturers Of America | $270,000 | — |
| lobbied by | Bavarian Nordic Inc | $270,000 | — |
| lobbied by | Inc. Merck & Co. | $255,000 | — |
| lobbied by | Astrazeneca | $245,000 | — |
| lobbied by | Inc. Amgen | $240,000 | — |
| lobbied by | Glaxosmithkline | $240,000 | — |
| lobbied by | Astrazeneca | $240,000 | — |
| lobbied by | Glaxosmithkline | $240,000 | — |
| lobbied by | Glaxosmithkline | $240,000 | — |
| lobbied by | Rai Services Company | $240,000 | — |
| lobbied by | Inc. Amgen | $240,000 | — |
| lobbied by | Astrazeneca | $240,000 | — |
| lobbied by | Glaxosmithkline | $240,000 | — |
| lobbied by | Amazon | $240,000 | — |
| lobbied by | Astrazeneca | $240,000 | — |
| lobbied by | Glaxosmithkline | $240,000 | — |
| lobbied by | Glaxosmithkline | $240,000 | — |
| lobbied by | Astrazeneca | $240,000 | — |
| lobbied by | Glaxosmithkline | $240,000 | — |
| lobbied by | Glaxosmithkline | $240,000 | — |
| lobbied by | Glaxosmithkline | $240,000 | — |
| lobbied by | Amazon | $240,000 | — |
| lobbied by | Astrazeneca | $240,000 | — |
| lobbied by | Glaxosmithkline | $240,000 | — |
| lobbied by | Glaxosmithkline | $240,000 | — |
| lobbied by | Longhorn | $240,000 | — |
| lobbied by | Bavarian Nordic Inc | $240,000 | — |
| lobbied by | Glaxosmithkline | $240,000 | — |
| lobbied by | Glaxosmithkline | $240,000 | — |
| lobbied by | Longhorn | $240,000 | — |
| lobbied by | Meso Scale Diagnostics | $240,000 | — |
| lobbied by | Inc. Exelixis | $230,000 | — |
| lobbied by | Alvogen | $225,000 | — |
| lobbied by | Bayer Corporation | $225,000 | — |
| lobbied by | Inc. Amgen | $225,000 | — |
| lobbied by | Bayer Corporation | $225,000 | — |
| lobbied by | Alere Inc. | $225,000 | — |